FILANA THERAPEUTICS, INC.
For the period ended Jun 30, 2026. Filed Jul 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Jul 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
During the quarter ended* June 30, 2026*, none of our directors or officers (as defined in Rule16a-1(f) of the Exchange Act) informed us of the adoption or termination of a “Rule10b5-1 trading arrangement” or “non-Rule10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item408.
28
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.